An official website of the United States government
Rates* of reported cases† of acute hepatitis C virus infection, by age group — United States, 2005-2020
Downloads of this figure: PDF PPT
Source: CDC, National Notifiable Diseases Surveillance System.
* Rates per 100,000 population.
† Reported confirmed cases. For the case definition, see Acute Hepatitis C.
Since 2010, rates of reported cases of acute hepatitis C consistently increased among all age groups of ≥20 years, with the exception of a decrease during 2018-2020 among persons 20-29 years old (from 3.0 to 2.8 per 100,000 population). In 2020, the rate of reported cases of acute hepatitis C has remained the highest among persons aged 20–39 years, similar to age groups at highest risk for fatal overdose in the United States and age at initiation of injection drug use among certain US populations.
Compared with 2019, the greatest increase in the rates of acute hepatitis C in 2020 were observed among those aged ≥ 60 years (60% increase), followed by those aged 50–59 years (27% increase). The rate of acute hepatitis C decreased slightly for a second year in a row among those aged 20–29 years. Rates have consistently been lowest among those aged <20 years or ≥60 years; however, rates have been increasing among those aged ≥60 years since 2015.
- Figure 3.1. Number of reported cases of acute hepatitis C virus infection and estimated infections — United States, 2013-2020
- Figure 3.2. Rates of reported cases of acute hepatitis C virus infection, by state or jurisdiction — United States, 2019-2020
- Figure 3.3. Rates of reported cases of acute hepatitis C virus infection, by state or jurisdiction — United States, 2020
- Figure 3.4. Rates of reported cases of acute hepatitis C virus infection, by age group — United States, 2005-2020
- Figure 3.5. Rates of reported cases of acute hepatitis C virus infection, by sex — United States, 2005-2020
- Figure 3.6. Rates of reported cases of acute hepatitis C virus infection, by race/ethnicity — United States, 2005-2020
- Figure 3.7. Availability of information on risk behaviors or exposures associated with reported cases of acute hepatitis C virus infection — United States, 2020
- Figure 3.8. Number of newly reported chronic hepatitis C virus infection cases by sex and age — United States, 2020
- Figure 3.9. Rates of death with hepatitis C virus infection listed as a cause of death among residents, by state or jurisdiction — United States, 2020
- Table 3.1. Numbers and rates of reported cases of acute hepatitis C virus infection, by state or jurisdiction — United States, 2016-2020
- Table 3.2. Numbers and rates of reported cases of acute hepatitis C virus infection, by demographic characteristics — United States 2016-2020
- Table 3.3. Reported risk behaviors or exposures among reported cases of acute hepatitis C virus infection — United States, 2020
- Table 3.4. Number of newly reported cases of perinatal hepatitis C virus infection, by state or jurisdiction — United States, 2020
- Table 3.5. Number and rate of newly reported cases of chronic hepatitis C virus infection, by state or jurisdiction — United States, 2020
- Table 3.6. Number and rate of newly reported cases of chronic hepatitis C virus infection, by demographic characteristics — United States, 2020
- Table 3.7. Numbers and rates of deaths with hepatitis C listed as a cause of death among residents, by state or jurisdiction — United States, 2016-2020
- Table 3.8. Numbers and rates of deaths with hepatitis C virus infection listed as a cause of death among residents, by demographic characteristics — United States, 2016-2020
Source:
- Jalal H, Buchanich JM, Sinclair DR, et al. Age and generational patterns of overdose death risk from opioids and other drugs. Nat Med 2020;26:699–704. doi: 10.1038/s41591-020-0855-y .